Caring for Machado-Joseph disease: Current understanding and how to help patients

Parkinsonism and Related Disorders

Volumn 16, Issue 1, 2010, Pages 2-7

  D'Abreu, Anelyssa ^a   França Jr , Marcondes C ^a   Paulson, Henry L ^b   Lopes Cendes, Iscia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CAG; Machado Joseph disease; SCA3; Spinocerebellar ataxia type 3

Indexed keywords

AMANTADINE; ATAXIN 3; BACLOFEN; BENZODIAZEPINE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVODOPA; METHYLPHENIDATE; MEXILETINE; MODAFINIL; POLYGLUTAMINE;

ATAXIA; BASAL GANGLION; BRAIN CORTEX; BRAIN STEM; CEREBELLUM; CHROMOSOME TRANSLOCATION 14; DEPRESSION; DISEASE SEVERITY; EXERCISE; FATIGUE; GENE LOCATION; GENE MUTATION; GENETIC CODE; GENETIC COUNSELING; HUMAN; MACHADO JOSEPH DISEASE; MOTOR DYSFUNCTION; MUSCLE CRAMP; NEUROIMAGING; OPHTHALMOPLEGIA; PAIN; PARKINSONISM; PATHOGENESIS; PERIPHERAL NEUROPATHY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PYRAMIDAL SIGN; QUALITY OF LIFE; REVIEW; SPINOCEREBELLAR DEGENERATION; THALAMUS;

DIAGNOSTIC IMAGING; GENOTYPE; HUMANS; MACHADO-JOSEPH DISEASE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; REPRESSOR PROTEINS;

EID: 74349086247     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.08.012     Document Type: Review

References (50)

1. Nakano K.K., Dawson D.M., and Spence A. Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts. Neurology 22 (1972) 49-55
2. Woods B.T., and Schaumburg H.H. Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia: a unique and partially treatable clinico-pathological entity. J Neurol Sci 17 (1972) 149-166
3. Rosenberg R.N., Nyhan W.L., Bay C., and Shore P. Autosomal dominant striato-nigral degeneration: a clinical, pathologic and biochemical study of a new genetic disorder. Neurology 26 (1976) 703-714
4. Romanul F.C.A., Fowler H.L., Radvany J., Feldman R.G., and Feingold M. Azorean disease of the nervous system. N Engl J Med 296 (1977) 1505-1508
5. Rosenberg R.N. Machado-Joseph disease: an autosomal dominant motor system degeneration. Mov Disord 7 (1992) 193-203
6. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8 (1994) 221-228
7. Carvalho D.R., La Rocque-Ferreira A., Rizzo I.M., Imamura E.U., and Speck-Martins C.E. Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr Neurol 38 (2008) 296-299
8. Maruyama H., Nakamura S., Matsuyama Z., Sakai T., Doyu M., Sobue G., et al. Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum Mol Genet 4 (1995) 807-812
9. Warrick J.M., Morabito L.M., Bilen J., Gordesky-Gold B., Faust L.Z., Paulson H.L., et al. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol Cell 18 (2005) 37-48
10. Winborn B.J., Travis S.M., Todi S.V., Scaglione K.M., Xu P., Williams A.J., et al. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits lys63 linkages in mixed linkage ubiquitin chains. J Biol Chem 283 (2008) 26436-26443
11. Evert B.O., Araujo J., Vieira-Saecker A.M., de Vos R.A., Harendza S., Klockgether T., et al. Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J Neurosci 26 (2006) 11474-11486
12. Williams A.J., and Paulson H.L. Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci 31 10 (2008) 521-528
13. Michalik A., and Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet 12 Spec No 2 (2003) R173-R186
14. Jardim L.B., Pereira M.L., Silveira I., Ferro A., Sequeiros J., and Giugliani R. Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n. Arch Neurol 58 (2001) 899-904
15. DeStefano A.L., Cupples L.A., Maciel P., Gaspar C., Radvany J., Dawson D.M., et al. A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease. Am J Hum Genet 59 (1996) 119-127
16. Schmitz-Hübsch T., Coudert M., Bauer P., Giunti P., Globas C., Baliko L., et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 71 (2008) 982-989
17. Rüb U., Brunt E.R., and Deller T. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease). Curr Opin Neurol 21 (2008) 111-116
18. Murata Y., Yamaguchi S., Kawakami H., Imon Y., Maruyama H., Sakai T., et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol 55 (1998) 33-37
19. Abe Y., Tanaka F., Matsumoto M., Doyu M., Hirayama M., Kachi T., et al. CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease. Neurology 51 (1998) 882-884
20. Onodera O., Idezuka J., Igarashi S., Takiyama Y., Endo K., Takano H., et al. Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease. Ann Neurol 43 (1998) 288-296
21. Horimoto Y., Matsumoto M., Yuasa H., Kojima A., Nokura K., Katada E., et al. Brainstem in Machado-Joseph disease: atrophy or small size?. Eur J Neurol 15 (2008) 102-105
22. Etchebehere E.C., Cendes F., Lopes-Cendes I., Pereira J.A., Lima M.C., Sansana C.R., et al. Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease. Arch Neurol 58 (2001) 1257-1263
23. Taniwaki T., Sakai T., Kobayashi T., Kuwabara Y., Otsuka M., Ichiya Y., et al. Positron emission tomography (PET) in Machado-Joseph disease. J Neurol Sci 145 (1997) 63-67
24. D'Abreu A., França Jr. M., Appenzeller S., Lopes-Cendes I., and Cendes F. Axonal dysfunction in the deep white matter in Machado-Joseph disease. J Neuroimaging 119 4 (2009) 277-280
25. Soong B.W., and Liu R.S. Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease. J Neurol Neurosurg Psychiatry 64 (1998) 499-504
26. Sakai T., and Kawakami H. Machado-Joseph disease: a proposal of spastic paraplegic subtype. Neurology 46 (1996) 846-847
27. Coutinho P. Doença de Machado-Joseph: Estudo Clínico, Patológico e Epidemiológico de uma Doença Neurológica de Origem Portuguesa (1994), Tipografia Nunes Ltda., Porto, Portugal
28. Gordon C.R., Joffe V., Vainstein G., and Gadoth N. Vestibulo-ocular arreflexia in families with spinocerebellar ataxia type 3 (Machado-Joseph disease). J Neurol Neurosurg Psychiatry 74 (2003) 1403-1406
29. Münchau A., Dressler D., Bhatia K.P., Vogel P., and Zühlke C. Machado-Joseph disease presenting as severe generalised dystonia in a German patient. J Neurol 246 (1999) 840-842
30. Wilder-Smith E., Tan E.K., Law H.Y., Zhao Y., Ng I., and Wong M.C. Spinocerebellar ataxia type 3 presenting as an l-DOPA responsive dystonia phenotype in a Chinese family. J Neurol Sci 213 (2003) 25-28
31. Gwinn-Hardy K., Singleton A., O'Suilleabhain P., Boss M., Nicholl D., Adam A., et al. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. Arch Neurol 58 (2001) 296-299
32. Klockgether T., Schöls L., Abele M., Bürk K., Topka H., Andres F., et al. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD). J Neurol Neurosurg Psychiatry 66 2 (1999) 222-224
33. Yeh T.H., Lu C.S., Chou Y.H., Chong C.C., Wu T., Han N.H., et al. Autonomic dysfunction in Machado-Joseph disease. Arch Neurol 62 (2005) 630-636
34. Friedman J.H., Fernandez H.H., and Sudarsky L.R. REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3). Mov Disord 18 (2003) 1520-1522
35. Schöls L., Haan J., Riess O., Amoiridis G., and Przuntek H. Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?. Neurology 51 (1998) 1603-1607
36. D'Abreu A., França Jr. M.C., Conz L., Friedman J.H., Nucci A., and Lopes-Cendes I. Sleep symptoms and their clinical correlates in Machado-Joseph Disease. Acta Neurol Scand 119 4 (2009) 277-280
37. Kawai Y., Takeda A., Abe Y., Washimi Y., Tanaka F., and Sobue G. Cognitive impairments in Machado-Joseph disease. Arch Neurol 61 (2004) 1757-1760
38. Zawacki T.M., Grace J., Friedman J.H., and Sudarsky L. Executive and emotional dysfunction in Machado-Joseph disease. Mov Disord 17 (2002) 1004-1010
39. Cecchin C.R., Pires A.P., Rieder C.R., Monte T.L., Silveira I., Carvalho T., et al. Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives. Community Genet 10 1 (2007) 19-26
40. França Jr. M.C., D'Abreu A., Friedman J.H., Nucci A., and Lopes-Cendes I. Chronic pain in Machado-Joseph disease: a frequent and disabling symptom. Arch Neurol 64 (2007) 1767-1770
41. França Jr. M.C., D'Abreu A., Nucci A., and Lopes-Cendes I. Muscle excitability abnormalities in Machado-Joseph disease. Arch Neurol 65 (2008) 525-529
42. Friedman J.H., and Amick M.M. Fatigue and daytime somnolence in Machado Joseph Disease (spinocerebellar ataxia type 3). Mov Disord 23 (2008) 1323-1324
43. Kieling C., Prestes P.R., Saraiva-Pereira M.L., and Jardim L.B. Survival estimates for patients with Machado-Joseph disease (SCA3). Clin Genet 72 (2007) 543-545
44. Cannella M., Simonelli M., D'Alessio C., Pierelli F., Ruggieri S., and Squitieri F. Presymptomatic tests in Huntington's disease and dominant ataxias. Neurol Sci 22 (2001) 55-56
45. Goodwin V.A., Richards S.H., Taylor R.S., Taylor A.H., and Campbell J.L. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord 23 5 (2008) 631-640
46. Benes H., and Kohnen R. Validation of an algorithm for the diagnosis of restless legs syndrome: the restless legs syndrome-diagnostic Index (RLS-DI). Sleep Med 10 5 (2009 May) 515-523
47. Hening W.A., Allen R.P., Washburn M., Lesage S.R., and Earley C.J. The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics"). Sleep Med 10 9 (2009) 976-981
48. Ferini-Strambi L. Treatment options for restless legs syndrome. Expert Opin Pharmacother 10 4 (2009 Mar) 545-554
49. Levine J., and Greenwald B.D. Fatigue in Parkinson disease, stroke, and traumatic brain injury. Phys Med Rehabil Clin N Am 20 2 (2009 May) 347-361
50. Adam O.R., and Jankovic J. Treatment of dystonia. Parkinsonism Relat Disord 13 Suppl. 3 (2007) S362-S368